What is the clinical evidence from this study?

Study design: Review. Population: Dyslipidemia and Coronary Artery Disease. Intervention: Genetic analyses.

What question did this study set out to answer?

The aim is to understand how genetic analyses improve diagnosis and treatment of dyslipidemia and coronary artery disease.

April 1, 2026

Clinical Perspectives of Genetic Analyses on Dyslipidemia and Coronary Artery Disease

View Full Paper

Ask AI

Bookmark

Key result

Lipid gene analyses aid dyslipidemia diagnosis, drug discovery, and CAD risk stratification.

Design

Review

Authors

HTHayato TadaKanazawa University MKMasa-aki KawashiriSociety of Interventional Radiology MYMasakazu YamagishiPreventive Cardiology

Discussion

Member takes

Implication

Genetic analyses of plasma lipids provide important insights for the diagnosis, risk stratification, and development of novel therapies for coronary artery disease.

Key Points

The aim is to understand how genetic analyses improve diagnosis and treatment of dyslipidemia and coronary artery disease.
Reviewed various case studies on familial hypercholesterolemia and Mendelian dyslipidemias.
Analyzed data from randomized controlled trials on LDL cholesterol lowering therapies.
Conducted Mendelian randomization studies examining lipid-associated gene variants.
LDL cholesterol is confirmed as a key cause of atherosclerosis.
Genetic analyses aid in diagnosing Mendelian dyslipidemias and identifying new treatment targets.
Genetic information enhances risk prediction and stratification for coronary artery disease.

PICO

Population

Dyslipidemia and Coronary Artery Disease

Exposure / Comparator

Genetic analyses

Genetic analyses of plasma lipids provide important insights for the diagnosis, risk stratification, and development of novel therapies for coronary artery disease.

Cite This Study

Tada et al. (2017) conducted a review in Dyslipidemia and Coronary Artery Disease. Genetic analyses was evaluated. Genetic analyses of lipid-associated genes contribute to the diagnosis of Mendelian dyslipidemias, discovery of novel therapeutic targets, and risk stratification for coronary artery disease.

synapsesocial.com/papers/69cd7aa45652765b073a7f68 https://doi.org/10.24517/00053013

View Full Paper

Ask AI

Bookmark

Implication

Genetic analyses of plasma lipids provide important insights for the diagnosis, risk stratification, and development of novel therapies for coronary artery disease.

Clinical Perspectives of Genetic Analyses on Dyslipidemia and Coronary Artery Disease

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Clinical Perspectives of Genetic Analyses on Dyslipidemia and Coronary Artery Disease

Discussion

Member takes

Implication

Key Points

PICO

Cite This Study

Also Consider

Also Consider